Skip to main content

Trilogy Capital Inc.

Position in BMY — Bristol Myers Squibb Co

CIK 1722512 IRVINE, CA

Position in BMY

as of Jun 30, 2026 · filed Jul 6, 2026
Position Value
$341,974
-$941 QoQ
Shares Held
5,935
+5.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,792
of 2,514 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Trilogy Capital Inc. holds $25,279,882 across 7 Drug Manufacturers - General names. BMY ranks #6 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 BMY
Bristol Myers Squibb Co
This page
5,935 $341,974

All Filings in BMY

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $341,974 5,935
2026-03-31 $342,915 5,654
2025-12-31 $319,109 5,916
2025-09-30 $279,439 6,196
2025-06-30 $214,693 4,638
2025-03-31 $328,004 5,378
2024-12-31 $1,363,661 24,110
2024-09-30 $3,421,152 66,122
2024-06-30 $2,728,645 65,703
2024-03-31 $3,280,047 60,484
2023-12-31 $2,709,475 52,806
2023-09-30 $2,880,235 49,625
2023-06-30 $469,265 7,338
2023-03-31 $392,779 5,667
2022-12-31 $328,020 4,559
2022-09-30 $263,459 3,706
2022-06-30 $285,824 3,712
2022-03-31 $254,947 3,491